Multiple Myeloma

Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. These cells are part of your immune system, which helps protect the body from germs and other harmful substances. In time, myeloma cells collect in the bone marrow and in the solid parts of bone.
What is Multiple Myeloma?

Multiple myeloma is a form of cancer that affects the bone marrow. The cancer is also called Kahler’s disease, named after an Austrian pathologist called Otto Kahler who first described the condition.

Read More

Overview

Feature Articles

Latest Multiple Myeloma News and Research

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

New drug shows promise to reverse treatment resistance in advanced multiple myeloma

A promising strategy to overcome drug resistance developed by blood cancer cells

A promising strategy to overcome drug resistance developed by blood cancer cells

Gero uses AI platform to identify potential anti-COVID-19 drugs

Gero uses AI platform to identify potential anti-COVID-19 drugs

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Genetic test could help doctors to identify patients with ultra high risk multiple myeloma

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Single gene cluster loss promotes initiation and progression of multiple myeloma in mice

Research reveals novel way to treat cancers using CAR T cell therapy

Research reveals novel way to treat cancers using CAR T cell therapy

AMSBIO announces new Custom CAR-T development service

AMSBIO announces new Custom CAR-T development service

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

New discovery could enable scientists to fine-tune activity of cancer-killing immune cells

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

IU researchers receive $3 million NIH grants to study cell functions in the bone marrow

SU2C announces international team for fighting gastric cancer

SU2C announces international team for fighting gastric cancer

Daratumumab proves effective in patients with relapsed AL amyloidosis

Daratumumab proves effective in patients with relapsed AL amyloidosis

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

The Riney Family Multiple Myeloma Initiative to be established at Dana-Farber

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

Researchers discover a way to move precision immunotherapy forward for multiple myeloma

New combination therapy can lead to durable responses in patients with multiple myeloma

New combination therapy can lead to durable responses in patients with multiple myeloma

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Risk of specific genetic translocation is higher in patients of African ancestry, shows study

Novel agent opens up new treatment option for patients with refractory myeloma

Novel agent opens up new treatment option for patients with refractory myeloma

Cancer patients have higher risk of cardiovascular death

Cancer patients have higher risk of cardiovascular death

Risk of death from heart disease found to be higher in cancer patients

Risk of death from heart disease found to be higher in cancer patients

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

New device separates malignant plasma cells from normal ones

New device separates malignant plasma cells from normal ones